Patrick Trucchio
Stock Analyst at H.C. Wainwright
(4.91)
# 188
Out of 5,032 analysts
1137
Total ratings
49.2%
Success rate
28.3%
Average return
Main Sectors:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHVS Pharvaris | Reiterated: Buy | $60 | $31.12 | +92.80% | 13 | Oct 6, 2026 | |
| AGMB AgomAb Therapeutics NV | Reiterated: Buy | $35 | $8.86 | +295.03% | 6 | Oct 2, 2026 | |
| IVVD Invivyd | Reiterated: Buy | $10 | $0.8064 | +1,140.08% | 42 | Sep 30, 2026 | |
| QURE uniQure | Reiterated: Buy | $80 | $23.06 | +246.92% | 63 | Sep 30, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $455 | $223.94 | +103.18% | 79 | Sep 21, 2026 | |
| ANRO Alto Neuroscience | Reiterated: Buy | $55 | $23.69 | +132.17% | 22 | Sep 21, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $120 | $61.54 | +95.00% | 74 | Sep 21, 2026 | |
| ASMB Assembly Biosciences | Reiterated: Buy | $50 | $22.18 | +125.43% | 17 | Sep 21, 2026 | |
| CMPS COMPASS Pathways | Reiterated: Buy | $65 | $11.56 | +462.28% | 62 | Sep 21, 2026 | |
| DRUG Bright Minds Biosciences | Reiterated: Buy | $145 | $48.25 | +200.52% | 16 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $6.20 | +867.74% | 68 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $26.89 | +123.13% | 4 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $90 | $10.78 | +734.88% | 52 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $29.64 | +237.38% | 54 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.01 | +890.10% | 9 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $2.94 | +1,430.61% | 14 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.598 | +736.12% | 52 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $9.83 | +662.97% | 44 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $11.60 | +72.41% | 68 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.46 | +916.26% | 30 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $35.62 | +96.52% | 46 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $25.23 | +217.08% | 30 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $2.67 | +649.06% | 50 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $39.36 | +39.74% | 28 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $5.38 | +829.37% | 22 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $21.52 | +202.04% | 40 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.14 | - | 51 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $10 | $0.7642 | n/a | 34 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $360 | $8.11 | n/a | 14 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.00 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.065 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 100p → 46p | 5p | n/a | 3 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €33.00 | €2.94 | n/a | 10 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $66 → $24 | $42.83 | n/a | 2 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $130 | $12.17 | n/a | 3 | Sep 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $117 → $72 | $14.00 | n/a | 2 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $20.83 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $3.63 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $125 | $96.77 | n/a | 1 | Dec 23, 2014 |
Pharvaris
Oct 6, 2026
Reiterated: Buy
Price Target: $60
Current: $31.12
Upside: +92.80%
AgomAb Therapeutics NV
Oct 2, 2026
Reiterated: Buy
Price Target: $35
Current: $8.86
Upside: +295.03%
Invivyd
Sep 30, 2026
Reiterated: Buy
Price Target: $10
Current: $0.8064
Upside: +1,140.08%
uniQure
Sep 30, 2026
Reiterated: Buy
Price Target: $80
Current: $23.06
Upside: +246.92%
Alnylam Pharmaceuticals
Sep 21, 2026
Reiterated: Buy
Price Target: $455
Current: $223.94
Upside: +103.18%
Alto Neuroscience
Sep 21, 2026
Reiterated: Buy
Price Target: $55
Current: $23.69
Upside: +132.17%
Arrowhead Pharmaceuticals
Sep 21, 2026
Reiterated: Buy
Price Target: $120
Current: $61.54
Upside: +95.00%
Assembly Biosciences
Sep 21, 2026
Reiterated: Buy
Price Target: $50
Current: $22.18
Upside: +125.43%
COMPASS Pathways
Sep 21, 2026
Reiterated: Buy
Price Target: $65
Current: $11.56
Upside: +462.28%
Bright Minds Biosciences
Sep 21, 2026
Reiterated: Buy
Price Target: $145
Current: $48.25
Upside: +200.52%
Sep 21, 2026
Reiterated: Buy
Price Target: $60
Current: $6.20
Upside: +867.74%
Sep 21, 2026
Reiterated: Buy
Price Target: $60
Current: $26.89
Upside: +123.13%
Sep 21, 2026
Reiterated: Buy
Price Target: $160 → $90
Current: $10.78
Upside: +734.88%
Sep 21, 2026
Reiterated: Buy
Price Target: $100
Current: $29.64
Upside: +237.38%
Sep 21, 2026
Reiterated: Buy
Price Target: $10
Current: $1.01
Upside: +890.10%
Sep 21, 2026
Reiterated: Buy
Price Target: $45
Current: $2.94
Upside: +1,430.61%
Sep 21, 2026
Reiterated: Buy
Price Target: $5
Current: $0.598
Upside: +736.12%
Sep 21, 2026
Reiterated: Buy
Price Target: $75
Current: $9.83
Upside: +662.97%
Sep 21, 2026
Reiterated: Buy
Price Target: $20
Current: $11.60
Upside: +72.41%
Sep 21, 2026
Reiterated: Buy
Price Target: $25
Current: $2.46
Upside: +916.26%
Sep 15, 2026
Reiterated: Buy
Price Target: $70
Current: $35.62
Upside: +96.52%
Sep 9, 2026
Reiterated: Buy
Price Target: $80
Current: $25.23
Upside: +217.08%
Aug 17, 2026
Reiterated: Buy
Price Target: $20
Current: $2.67
Upside: +649.06%
Aug 12, 2026
Reiterated: Buy
Price Target: $55
Current: $39.36
Upside: +39.74%
Aug 10, 2026
Reiterated: Buy
Price Target: $50
Current: $5.38
Upside: +829.37%
Aug 10, 2026
Reiterated: Buy
Price Target: $65
Current: $21.52
Upside: +202.04%
Jun 9, 2026
Rated: Hold
Price Target: n/a
Current: $0.14
Upside: -
Apr 2, 2025
Reiterated: Buy
Price Target: $25 → $10
Current: $0.7642
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $20 → $360
Current: $8.11
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $9.00
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.065
Upside: n/a
Nov 2, 2022
Reiterated: Buy
Price Target: 100p → 46p
Current: 5p
Upside: n/a
Mar 27, 2020
Reiterated: Buy
Price Target: €33.00
Current: €2.94
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $66 → $24
Current: $42.83
Upside: n/a
Sep 18, 2019
Reiterated: Buy
Price Target: $120 → $130
Current: $12.17
Upside: n/a
Nov 13, 2018
Downgraded: Hold
Price Target: $117 → $72
Current: $14.00
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $22
Current: $20.83
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $25
Current: $3.63
Upside: n/a
Dec 23, 2014
Upgraded: Buy
Price Target: $125
Current: $96.77
Upside: n/a